Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria - Kulasekararaj, Austin; Brodsky, Robert; Schrezenmeier, Hubert; Griffin, Morag; Roeth, Alexander; Piatek, Caroline; Ogawa, Masayo; Yu, Ji; Patel, Ami S; Gualandro, Sandra Fátima Menosi (Annals of hematology, 2025)